Regional anaesthesia

Transcutaneous auricular vagus nerve stimulation to prevent rebound pain after interscalene block for arthroscopic shoulder surgery

Reg Anesth Pain MedPublished Randomised controlled trial

Authors' conclusion

Perioperative taVNS may reduce the incidence of rebound pain following single-shot ISB in patients undergoing arthroscopic shoulder surgery.

Study context

Population
Adults undergoing elective arthroscopic shoulder surgery with ultrasound-guided single-shot interscalene blockall completed, ITT
Participants
120 adults
Comparison
Active transcutaneous auricular vagus nerve stimulation (taVNS) vs sham stimulation
  • taVNSn = 60
  • Shamn = 60reference
Primary endpoint
Incidence of rebound pain
Follow-up
Within 24 hours after surgery
Methodological detailssingle-centre, participant- and assessor-blinded, sham-controlled
  • Single-centre
  • Participant- and assessor-blinded
  • Sham-controlled

Primary result

As reported in the abstract

Each group vs shamRelative risk (95% CI)P value
taVNS
0.46(0.26–0.82)
P = 0.006
taVNS
absolute risk reduction 23.3% (95% CI 7.2%–39.5%)
taVNS
NNT 4.3 (95% CI 2.5–13.9)

Secondary outcomes

OutcomeMean difference (95% CI)P value
Resting pain scores−0.50 (−0.63 to −0.37)P < 0.001
Movement-evoked pain scores−0.39 (−0.65 to −0.14)P = 0.003

Quality of recovery (QoR-15) and sleep quality (Richards-Campbell Sleep Questionnaire) · POD 1 and 2 (QoR-15); night of surgery and postoperative night 1 (sleep)

Higher QoR-15 scores and better sleep quality with taVNS
all p<0.01

Cumulative sufentanil consumption

Between-group difference not statistically significant (GMR)
0.67
  • 95% CI 0.44 to 1.01; p=0.056

Safety

No stimulation-related adverse events observed

Original publication

Transcutaneous auricular vagus nerve stimulation to prevent rebound pain after interscalene block for arthroscopic shoulder surgery. Reg Anesth Pain Med. Published 15 September 2026. doi:10.1136/rapm-2026-108256

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.